Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Different Bispectral Index Guided Remimazolam Total Intravenous Anesthesia-flumazenil Antagonism in Short-duration Ear Nose Throat Surgeries: A Retrospective Cohort Study

NCT07389798 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07389798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07389798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Different Bispectral Index Guided Remimazolam Total Intravenous Anesthesia-flumazenil Antagonism in Short-duration Ear Nose Throat Surgeries: A Retrospective Cohort Study
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Completed
Start date
March 9, 2026
Completion date
April 4, 2026
Enrollment
511 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bispectral index, remimazolam, total intravenous anesthesia